+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Outcomes of a Single Surgeon-Based Transanal-Total Mesorectal Excision (TATME) for Rectal Cancer



Outcomes of a Single Surgeon-Based Transanal-Total Mesorectal Excision (TATME) for Rectal Cancer



Journal of Gastrointestinal Cancer 49(4): 455-462



Several studies have shown the transanal total mesorectal excision (TATME) is emerging as a safe and effective technique for proctectomy. The majority of these studies to date, however, is based on procedures done in centers with teams of two surgeons working simultaneously. Few were performed by single-surgeon teams with sizeable case load. The objective of our study was to identify the feasibility and safety of a single-surgeon TATME. Chart review of prospectively collected data on 27 patients who underwent TATME at our institution from June 2015 to September 2016 were included in this study. Indications for TATME included mid and low rectal cancers. Only patients who underwent surgery for neoplastic lesions were included in the study. Outcomes assessed included mesorectal integrity, margin status, operative time, complications, morbidity, LOS, and 30-day readmission. A total of 27 cases were available for inclusion. A single surgeon performed all procedures. The average BMI was 27.2 ± 1.3 kg/m2. The average tumor distance from anal verge was 6.8 ± 0.6 cm. The median operative time was 283 min. No intraoperative complications, including injuries and conversions, occurred. Circumferential resection margin (CRM) and distal resection margin (DRM) were R0 in 96 and 100% of patients, respectively. Mesorectal integrity was "Complete" in 67% and "Near complete" in 33% of patients. There were no incomplete specimens. The total lymph node (LN) harvest was 26 ± 2. The average LOS was 4 days for 75% of all patients. There were no mortalities. The overall morbidity was 33% (9/27). There were 4/27 anastomotic leaks, one required a laparoscopic ileostomy, one had laparoscopic drainage of an abscess, and the other two were endoscopically washed and trans-rectal drains inserted. TATME performed by a one-surgeon team is oncologically adequate, and it is safe and feasible. Morbidities are comparable with existing literature data from two-surgeon teams. In addition, resection margins, mesorectal integrity, and LN harvests are also comparable or superior to some of the existing studies.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 060056759

Download citation: RISBibTeXText

PMID: 28702861

DOI: 10.1007/s12029-017-9989-7


Related references

Transanal total mesorectal excision (taTME) for rectal cancer: a systematic review and meta-analysis of oncological and perioperative outcomes compared with laparoscopic total mesorectal excision. Bmc Cancer 16: 380, 2017

Residual mesorectum on postoperative magnetic resonance imaging following transanal total mesorectal excision (TaTME) and laparoscopic total mesorectal excision (LapTME) in rectal cancer. Surgical Endoscopy 2018, 2018

Transanal total mesorectal excision (TaTME) of a low rectal cancer using transanal minimally invasive surgery. Ceylon Medical Journal 62(4): 244-245, 2018

Transanal total mesorectal excision (TaTME) versus laparoscopic TME for MRI-defined low rectal cancer: a propensity score-matched analysis of oncological outcomes. Surgical Endoscopy 2018, 2018

Laparoscopic Transanal Total Mesorectal Excision (taTME) for Rectal Cancer. Journal of Gastrointestinal Surgery 19(10): 1880-1888, 2016

Transanal total mesorectal excision (taTME) in a single-surgeon setting: refinements of the technique during the learning phase. Techniques in Coloproctology 22(6): 433-443, 2018

An Initial Experience Comparing Robotic Total Mesorectal Excision (RTME) and Transanal Total Mesorectal Excision (taTME) for Low Rectal Tumours. Annals of the Academy of Medicine, Singapore 47(5): 188-190, 2018

Transanal Total Mesorectal Excision (TaTME) and Quality of Rectal Cancer Surgery: Do we Really Know?. Annals of Surgery 266(6): E88-E89, 2016

Transanal total mesorectal excision (taTME) for rectal cancer: a training pathway. Surgical Endoscopy 30(9): 4130-4135, 2017

Transanal total mesorectal excision (TaTME) for primary rectal cancer : Video article. Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 88(10): 863-866, 2017

Combined transanal total mesorectal excision (taTME) with laparoscopic instruments and abdominal robotic surgery in rectal cancer. Techniques in Coloproctology 21(3): 233-235, 2017

Transanal Total Mesorectal Excision in Lower Rectal Cancer: Comparison of Short-Term Outcomes with Conventional Laparoscopic Total Mesorectal Excision. Journal of Laparoendoscopic and Advanced Surgical Techniques. Part a 28(4): 365-369, 2017

Transanal Total Mesorectal Excision (taTME) for Rectal Cancer: A Case Series Report of a Natural Orifice Surgical Technique. American Surgeon 84(10): 1655-1660, 2019

Transanal total mesorectal excision for low rectal cancer: a case-matched study comparing TaTME versus standard laparoscopic TME. Cancer Management and Research 10: 5239-5245, 2018

Transanal total mesorectal excision (TaTME) for rectal cancer: effects on patient-reported quality of life and functional outcome. Techniques in Coloproctology 21(1): 25-33, 2017